MA
Macdonald Alistair
Chairman & CEO
C-suiteM
€356,582
▼ Sales (11 ops.)
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Macdonald Alistair, Chairman & CEO. Insider active across 2 companies, notably Syneos Health, Inc.. In total, 19 reports have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €357k. Activity tracked since 1 June 2021. The latest transaction was disclosed on 2 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Macdonald Alistair
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
36,727 shares0Class A Common StockSEC:0001209191-22-016379:0
15,028 shares@ US$86.0945.4% of flowClass A Common StockSEC:0001209191-22-004114:0
10,154 shares@ US$93.6933.5% of flowClass A Common StockSEC:0001209191-22-003086:0
4,710 shares@ US$89.9014.3% of flowClass A Common StockSEC:0001209191-21-049715:0
4,889 shares@ US$42.886.9% of flowClass A Common StockSEC:0001209191-21-037755:0
11,000 sharesClass A Common StockSEC:0001624073-16-000007:0
46,982 sharesClass A Common StockSEC:0001624073-16-000006:0
31,241 sharesClass A Common StockSEC:0001624073-16-000006:1
20,366 sharesClass A Common StockSEC:0001624073-16-000006:2
10,427 sharesClass A Common StockSEC:0001624073-16-000006:3
448 sharesClass A Common StockSEC:0001624073-16-000006:4
52,972 sharesClass A Common StockSEC:0001624073-16-000006:5
34,521 sharesClass A Common StockSEC:0001624073-16-000006:6
17,690 sharesClass A Common StockSEC:0001624073-16-000006:7
761 sharesClass A Common StockSEC:0001624073-16-000006:8
28,404 sharesClass A Common StockSEC:0001624073-16-000006:9
18,513 sharesClass A Common StockSEC:0001624073-16-000006:10
9,483 sharesClass A Common StockSEC:0001624073-16-000006:11
408 sharesClass A Common StockSEC:0001624073-16-000006:12
About Macdonald Alistair
Macdonald Alistair is Président-Directeur Général. He has filed 19 disclosures in total, and across the sample of the 19 most recent filings, the transactions are dominated by disposals, with total sales of EUR 356582 between 2016-01-04 and 2022-03-04, mainly at Syneos Health, Inc. and INC Research Holdings, Inc.